Nancy Dgetluck

Randomized, Double-Blind, Placebo-Controlled Study of Encenicline, an α7 Nicotinic Acetylcholine Receptor Agonist, as a Treatment for Cognitive Impairment in Schizophrenia

Richard S.E. Keefe, Herbert Meltzer, Nancy Dgetluck et al. · Neuropsychopharmacology · 2015 · 147 citations · Full text

Medicine, Pharmacology, Psychiatry +17

Safety and Efficacy of Lenabasum in a Phase II, Randomized, Placebo‐Controlled Trial in Adults With Systemic Sclerosis

Robert Spiera, Laura K. Hummers, Tracy Frech et al. · Arthritis & Rheumatology · 2020 · 104 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale

Richard S.E. Keefe, Vicki G. Davis, Nathan B. Spagnola et al. · European Neuropsychopharmacology · 2014 · 69 citations · Full text

Social Sciences, Psychiatry, Psychology +14

Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosis

James F. Chmiel, Patrick A. Flume, D.G. Downey et al. · Journal of Cystic Fibrosis · 2020 · 68 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +6

Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial

Victoria P. Werth, Emily Z. Hejazi, S.M. Peña et al. · Journal of Investigative Dermatology · 2022 · 53 citations · Full text

Medicine, Dermatology, Pharmacology +12